Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
15%
OVERLAP
BY WEIGHT
14
# OF OVERLAPPING
HOLDINGS
BBP
70
HOLDINGS
23%
ALSO IN CANC
CANC
56
HOLDINGS
25%
ALSO IN BBP
SECTOR DRIFT (BBP minus CANC)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in BBP |
Weight in CANC |
Overlap | |
|---|---|---|---|---|
 |
ZAI LAB LTD. UNSPONSORED ADR | 1.5% | 1.9% | 1.5% |
 |
BRIDGEBIO PHARMA, INC. | 1.4% | 2.6% | 1.4% |
|
HALOZYME THERAPEUTICS INC | 1.4% | 3.0% | 1.4% |
|
EXELIXIS INC | 1.4% | 2.8% | 1.4% |
|
IOVANCE BIOTHERAPEUTICS INC | 1.4% | 1.6% | 1.4% |
BBP Overweight Relative to CANC
|
OMEROS CORP | 1.7% |
|
AGIOS PHARMACEUTICALS INC | 1.7% |
|
SAREPTA THERAPEUTICS INC | 1.6% |
|
ULTRAGENYX PHARMACEUTICAL IN | 1.6% |
|
CYTOKINETICS INC | 1.6% |
|
ARROWHEAD PHARMACEUTICALS, INC. | 1.6% |
|
KRYSTAL BIOTECH, INC. | 1.6% |
|
RHYTHM PHARMACEUTICALS, INC. | 1.6% |
|
GERON CORP | 1.6% |
|
CRISPR THERAPEUTICS AG | 1.6% |
BBP Underweight Relative to CANC
|
REVOLUTION MEDICINES, INC. | -5.5% |
|
COGENT BIOSCIENCES INC | -5.0% |
|
MERCK & CO. INC. | -4.6% |
|
ELI LILLY & CO | -4.4% |
 |
NOVARTIS AG | -3.6% |
|
BRISTOL-MYERS SQUIBB CO | -3.6% |
|
ABBVIE INC | -3.5% |
|
JOHNSON & JOHNSON | -3.2% |
|
ROCHE HOLDINGS LTD-SPONS ADR | -3.1% |
 |
GENMAB A/S SPONSORED ADR | -2.9% |